Related Experiment Videos
[Smoking and inflammatory bowel disease: an epidemiological case-control study]
E V Martins Júnior1, I S Araújo, A N Atallah
1Escola Paulista de Medicina, Universidade Federal de São Paulo--UNIFESP-EPM.
Arquivos De Gastroenterologia
|April 1, 1996
Summary
Smoking appears to protect against ulcerative colitis but not Crohn's disease. Quitting smoking may increase the risk for both inflammatory bowel diseases, suggesting a need for further research into tobacco's effects.
Area of Science:
- Gastroenterology
- Epidemiology
- Oncology
Context:
- Inflammatory bowel disease (IBD) encompasses ulcerative colitis (UC) and Crohn's disease (CD).
- Smoking is a known epidemiological factor in IBD, with distinct associations for UC and CD.
- Previous research suggests smoking protects against UC but may increase CD risk.
Purpose:
- To investigate the relationship between smoking habits and the development of ulcerative colitis and Crohn's disease.
- To assess the impact of smoking cessation on IBD onset.
- To examine the role of childhood environmental tobacco smoke exposure in IBD risk.
Summary:
- Smoking showed a protective effect against ulcerative colitis (OR: 0.30), but not Crohn's disease (OR: 0.81).
- Ex-smokers had higher rates of developing ulcerative colitis (72.7%) and Crohn's disease (44.4%) after quitting.
- Childhood environmental tobacco smoke exposure did not significantly increase the risk for either IBD.
Impact:
- Findings support the protective role of smoking in ulcerative colitis, aligning with existing literature.
- The study highlights potential risks associated with smoking cessation for IBD patients.
- Further research is warranted to elucidate the pharmacological mechanisms of tobacco in IBD management.